Oramed Pharmaceuticals Inc (ORMP)
2.40
+0.07
(+3.00%)
USD |
NASDAQ |
Apr 23, 16:00
2.40
0.00 (0.00%)
After-Hours: 18:49
Oramed Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
November 30, 2021 | 0.00 |
August 31, 2021 | 0.00 |
May 31, 2021 | 0.00 |
February 28, 2021 | 0.00 |
November 30, 2020 | 0.00 |
August 31, 2020 | 0.00 |
May 31, 2020 | 0.00 |
February 29, 2020 | 0.00 |
November 30, 2019 | 0.00 |
Date | Value |
---|---|
August 31, 2019 | 0.00 |
May 31, 2019 | 0.00 |
February 28, 2019 | 0.00 |
November 30, 2018 | 0.00 |
August 31, 2018 | 0.00 |
May 31, 2018 | 0.00 |
February 28, 2018 | 0.00 |
November 30, 2017 | 0.00 |
August 31, 2017 | 0.00 |
May 31, 2017 | 0.00 |
February 28, 2017 | 0.00 |
November 30, 2016 | 0.00 |
August 31, 2016 | 0.00 |
May 31, 2016 | 0.00 |
February 29, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
May 2019
--
Maximum
May 2019
--
Average
--
Median
May 2019
Debt to Equity Ratio Benchmarks
Inogen Inc | 0.00 |
Petros Pharmaceuticals Inc | 0.6421 |
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 220.55M |
Total Liabilities (Quarterly) | 57.66M |
Shareholders Equity (Quarterly) | 163.82M |